Scancell to Acquire Neuphoria, Concurrent $89 Million Private Financing
July 24, 2026
July 24, 2026
PALO ALTO, California, July 24 -- Cooley, a law firm, issued the following news release:
* * *
Scancell to Acquire Neuphoria, Concurrent $89 Million Private Financing
Cooley advised Scancell, a late-stage clinical biotechnology company, on its agreement to acquire Neuphoria Therapeutics, a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. Upon completi . . .
* * *
Scancell to Acquire Neuphoria, Concurrent $89 Million Private Financing
Cooley advised Scancell, a late-stage clinical biotechnology company, on its agreement to acquire Neuphoria Therapeutics, a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. Upon completi . . .